Relative to other tumor types, that are more amenable to immunotherapy, the microenvironment for GBM is particularly immunosuppressive, harboring high densities of CD8 T cell-suppressive cytokines, myeloid-derived suppressive cells and regulatory T cells [22,23,24]. Here, CD8A is linked to glioblastoma.